Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: The involvement of peroxisome proliferator-activated receptor α and hypoxia-inducible factor-2α signaling

Molecular Pharmacology

Volumn 76, Issue 3, 2009, Pages 588-595

  Tuller, Erin R ^a   Beavers, Charles T ^a   Lou, Jessica R ^a   Ihnat, Michael A ^a   Benbrook, Doris M ^a   Ding, Wei Qun ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CLOFIBRATE; COPPER ZINC SUPEROXIDE DISMUTASE; DOCOSAHEXAENOIC ACID; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE;

ARTICLE; CANCER CELL; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PRIORITY JOURNAL; PROMOTER REGION; TIME; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CLOFIBRATE; DOCOSAHEXAENOIC ACIDS; HUMANS; LIGANDS; PPAR ALPHA; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 69549096508     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057430     Document Type: Article

References (42)

1. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, and O'Rahilly S (1997) Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153. (Pubitemid 28022853)
2. Bégin ME, Ells G, and Horrobin DF (1988) Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80:188-194. (Pubitemid 18100564)
3. Bianchi L, Tacchini L, and Cairo G (1999) HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res 27:4223-4227. (Pubitemid 29500256)
4. Bougnoux P (1999) n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 2:121-126. (Pubitemid 129627808)
5. Burns CP, Halabi S, Clamon GH, Hars V, Wagner BA, Hohl RJ, Lester E, Kirshner JJ, Vinciguerra V, and Paskett E (1999) Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 5:3942-3947. (Pubitemid 30013768)
6. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, and Palozza P (2004) n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25:2303-2310. (Pubitemid 39625169)
7. Canuto RA, Muzio G, Maggiora M, Trombetta A, Martinasso G, Autelli R, Costelli P, Bonelli G, and Baccino FM (2003) Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase. J Lipid Res 44:56-64. (Pubitemid 36114770)
8. Collett ED, Davidson LA, Fan YY, Lupton JR, and Chapkin RS (2001) n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 280:C1066-C1075. (Pubitemid 32433740)
9. Crapo JD, Oury T, Rabouille C, Slot JW, and Chang LY (1992) Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci U S A 89:10405-10409.
10. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, and Staels B (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048-32054. (Pubitemid 129503797)
11. Delerive P, Gervois P, Fruchart JC, and Staels B (2000) Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 275:36703-36707. (Pubitemid 32002075)
12. Desvergne B and Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688. (Pubitemid 30650602)
13. Diep QN, Touyz RM, and Schiffrin EL (2000) Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36:851-855.
14. Ding WQ and Lind SE (2007) Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol Cancer Ther 6:1467-1474.
15. Ding WQ, Liu B, Vaught JL, Palmiter RD, and Lind SE (2006) Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther 5:1864-1872. (Pubitemid 44323255)
16. Ding WQ, Vaught JL, Yamauchi H, and Lind SE (2004) Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. Mol Cancer Ther 3:1109-1117. (Pubitemid 39295008)
17. Fridovich I (1995) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64:97-112.
18. Garg ML, Leitch J, Blake RJ, and Garg R (2006) Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation. Lipids 41:1127-1132. (Pubitemid 46095225)
19. Gonzalez MJ (1995) Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr 14:325-335.
20. Göttlicher M, Widmark E, Li Q, and Gustafsson JA (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A 89:4653-4657.
21. Hardman WE (2004) (n-3) fatty acids and cancer therapy. J Nutr 134 (12 Suppl):3427S-3430S.
22. Hashimoto F, Oguchi Y, Morita M, Matsuoka K, Takeda S, Kimura M, and Hayashi H (2004) PPARalpha agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and up-regulate progesterone secretions in immortalized human trophoblast cells. Biochem Pharmacol 68:313-321. (Pubitemid 38757700)
23. Hawkins RA, Sangster K, and Arends MJ (1998) Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185:61-70. (Pubitemid 28266718)
24. Huang H, Starodub O, McIntosh A, Kier AB, and Schroeder F (2002) Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 277:29139-29151.
25. Huang P, Feng L, Oldham EA, Keating MJ, and Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407:390-395. (Pubitemid 30736017)
26. Juarez JC, Betancourt O Jr, Pirie-Shepherd SR, Guan X, Price ML, Shaw DE, Mazar AP, and Doñate F (2006) Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 12:4974-4982. (Pubitemid 44338586)
27. Kim HT, Kim YH, Nam JW, Lee HJ, Rho HM, and Jung G (1994) Study of 5′-flanking region of human Cu/Zn superoxide dismutase. Biochem Biophys Res Commun 201:1526-1533. (Pubitemid 24234262)
28. Kinnula VL and Crapo JD (2004) Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 36:718-744. (Pubitemid 38264416)
29. Leonardi F, Attorri L, Di Benedetto R, Di Biase A, Sanchez M, Nardini M, and Salvati S (2005) Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells. Free Radic Res 39:865-874. (Pubitemid 40975080)
30. Marikovsky M, Ziv V, Nevo N, Harris-Cerruti C, and Mahler O (2003) Cu/Zn superoxide dismutase plays important role in immune response. J Immunol 170:2993-3001. (Pubitemid 36302172)
31. Merendino N, Loppi B, D'Aquino M, Molinari R, Pessina G, Romano C, and Velotti F (2005) Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 52:225-233. (Pubitemid 41579764)
32. Ng Y, Barhoumi R, Tjalkens RB, Fan YY, Kolar S, Wang N, Lupton JR, and Chapkin RS (2005) The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 26:1914-1921. (Pubitemid 41631264)
33. Oberley TD and Oberley LW (1997) Antioxidant enzyme levels in cancer. Histol Histopathol 12:525-535.
34. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, and Kamatani N (2005) Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 23:323-330. (Pubitemid 40823539)
35. Pacifici RE and Davies KJ (1991) Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37:166-180.
36. Rojo AI, Salinas M, Martín D, Perona R, and Cuadrado A (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24:7324-7334. (Pubitemid 39100701)
37. Salnikow K, An WG, Melillo G, Blagosklonny MV, and Costa M (1999) Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20:1819-1823.
38. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, et al. (1998) Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393:790-793. (Pubitemid 28299490)
39. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y, and Phang JM (2008) Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122:1435-1440. (Pubitemid 351287248)
40. Tuller ER, Brock AL, Yu H, Lou JR, Benbrook DM, and Ding WQ (2009) PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 77:1480-1486.
41. Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, and Chen CS (2007) Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Cancer Res 67:3229-3238. (Pubitemid 46724861)
42. Yoo HY, Chang MS, and Rho HM (1999) The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 274:23887-23892. (Pubitemid 129528429)